Feasibility and efficacy of modified fixed citrate concentration protocol using only commercial preparations in critically ill patients: a prospective cohort study with a historical control group

Table 3 Reasons for stopping continuous veno-venous hemofiltration

	Fixed group	Titrated group	P value
Spontaneous circuit failure, n (%)
Clotting	10 (15.2)	19 (29.7)	0.047
Catheter dysfunction	3 (4.5)	4 (6.3)	0.667
Elective discontinuation, n (%)
Replaced as planned after 72 h	45 (68.2)	34 (53.1)	0.079
Clinical target achievement	4 (6.1)	3 (4.7)	0.729
Death	3 (4.5)	2 (3.1)	0.674
Citrate Accumulation	1 (1.5)	2 (3.1)	0.541

ISSN: 1471-2253